SCHEMBL24670015

SCHEMBL24670015

NS(=O)(=O)c1cc(C=O)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA9 Q16790 4/20 0.41
KDM4E B2RXH2 1/20 0.41
PTGS2 P35354 1/20 0.41
RAB9A P51151 1/20 0.41
STS P08842 1/20 0.40
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTGES2 Q9H7Z7 6/20 0.38
TET2 Q6N021 1/20 0.37
CA7 P43166 2/20 0.36
CA13 Q8N1Q1 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23200538 0.85 ALDH1A1 (0.42) CA12CA1CA2CA9KDM4E
SCHEMBL7754930 0.81 PTGS2 (0.39) KDM4EPTGS2RAB9AALDH1A1SMN1; SMN2
SCHEMBL10451439 0.79 RAB9A (0.39) KDM4EPTGS2RAB9AALDH1A1SMN1; SMN2
SCHEMBL10451438 0.79 ALDH1A1 (0.38) CA12CA1CA2CA9KDM4E
SCHEMBL939715 0.77 ALDH1A1 (0.55) CA12CA1CA2CA9KDM4E
SCHEMBL18231235 0.77 CA1 (0.43) CA12CA1CA2CA9KDM4E
SCHEMBL31391620 0.77 CA1 (0.41) CA12CA1CA2CA9KDM4E
SCHEMBL10688788 0.77 CA12 (0.50) CA12CA1CA2CA9KDM4E
SCHEMBL1127112 0.75 PTGES2 (0.49) CA12CA1CA2CA9PTGS2
SCHEMBL29721599 0.75 PTGES2 (0.49) CA12CA1CA2CA9PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154314-A1 SPIRO PIPERIDINE DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed